Ras inhibitors and methods of use thereof
MX2026004020APending Publication Date: 2026-10-02KESTREL THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MX2026004020
- Authority / Receiving Office
- MX · MX
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-07
- Filing Date
- 2026-04-01
- Publication Date
- 2026-10-02
Abstract
The disclosure provides compounds, e.g., compounds of Formula I, and their use in treating medical diseases or disorders, such as cancer. Pharmaceutical compositions and methods of making various indene compounds are provided. The compounds are contemplated to be modulators of Ras (e.g., K-Ras).
Need to check novelty before this filing date? Find Prior Art